Celldex Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| WELLINGTON MANAGEMENT GROUP LLP | 02/12/2025 | 8.98 M | $226.82 M | -2.90% | 13.54% |
| BLACKROCK FUNDING, INC. /DE | 02/07/2025 | 5.48 M | $138.50 M | 12.31% | 8.27% |
| KYNAM CAPITAL MANAGEMENT, LP | 02/14/2025 | 5.06 M | $127.97 M | 46.42% | 7.64% |
| FMR LLC | 02/13/2025 | 4.86 M | $122.75 M | -19.37% | 7.33% |
| VANGUARD GROUP INC | 02/11/2025 | 3.88 M | $98.10 M | 0.32% | 5.86% |
| EVENTIDE ASSET MANAGEMENT, LLC | 02/14/2025 | 3.75 M | $94.84 M | 12.64% | 5.66% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 02/14/2025 | 3.56 M | $89.89 M | 23.50% | 5.37% |
| STATE STREET CORP | 02/14/2025 | 3.23 M | $81.75 M | 30.17% | 4.88% |
| BELLEVUE GROUP AG | 02/14/2025 | 3.07 M | $77.62 M | 0.00% | 4.63% |
| POINT72 ASSET MANAGEMENT, L.P. | 02/14/2025 | 2.52 M | $63.58 M | 60.39% | 3.80% |
| JEFFERIES FINANCIAL GROUP INC. | 02/27/2025 | 2.39 M | $60.41 M | 11,282.85% | 3.61% |
| WOODLINE PARTNERS LP | 02/14/2025 | 2.01 M | $50.89 M | -13.97% | 3.04% |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 02/14/2025 | 1.70 M | $42.90 M | -2.13% | 2.56% |
| POLAR CAPITAL HOLDINGS PLC | 02/14/2025 | 1.57 M | $39.57 M | -42.45% | 2.36% |
| DEEP TRACK CAPITAL, LP | 02/14/2025 | 1.54 M | $38.92 M | 100.00% | 2.32% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 1.53 M | $38.80 M | -0.36% | 2.32% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 02/14/2025 | 1.22 M | $30.88 M | 10.73% | 1.84% |
| GOLDMAN SACHS GROUP INC | 02/11/2025 | 1.20 M | $30.39 M | -34.50% | 1.81% |
| PICTET ASSET MANAGEMENT HOLDING SA | 02/12/2025 | 1.09 M | $27.55 M | -4.24% | 1.64% |
| NOVO HOLDINGS A/S | 02/14/2025 | 1.00 M | $25.27 M | 3.77% | 1.51% |
| EVERSEPT PARTNERS, LP | 02/14/2025 | 719,836 | $18.19 M | 27.43% | 1.09% |
| REDMILE GROUP, LLC | 02/14/2025 | 615,775 | $15.56 M | -6.30% | 0.93% |
| AMERICAN CENTURY COMPANIES INC | 02/11/2025 | 608,457 | $15.38 M | 46.49% | 0.92% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 544,330 | $13.76 M | 1.02% | 0.82% |
| D. E. SHAW & CO., INC. | 02/14/2025 | 518,340 | $13.10 M | -37.18% | 0.78% |
| 5AM VENTURE MANAGEMENT, LLC | 02/14/2025 | 497,270 | $12.57 M | 0.00% | 0.75% |
| SPHERA FUNDS MANAGEMENT LTD. | 02/14/2025 | 474,103 | $11.98 M | 13.12% | 0.72% |
| FISHER ASSET MANAGEMENT, LLC | 02/05/2025 | 452,497 | $11.43 M | 20.87% | 0.68% |
| UBS GROUP AG | 02/14/2025 | 389,797 | $9.85 M | 133.98% | 0.59% |
| CAPTION MANAGEMENT, LLC | 02/14/2025 | 373,000 | $9.43 M | 6.57% | 0.56% |
| VESTAL POINT CAPITAL, LP | 02/14/2025 | 305,000 | $7.71 M | 100.00% | 0.46% |
| CRESTLINE MANAGEMENT, LP | 02/14/2025 | 295,354 | $7.46 M | 114.04% | 0.45% |
| NUVEEN ASSET MANAGEMENT, LLC | 02/14/2025 | 288,378 | $7.29 M | -20.70% | 0.44% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 02/14/2025 | 264,560 | $6.69 M | 82.46% | 0.40% |
| BAKER BROS. ADVISORS LP | 02/14/2025 | 247,644 | $6.26 M | 0.00% | 0.37% |
| TSP CAPITAL MANAGEMENT GROUP, LLC | 01/30/2025 | 223,343 | $5.64 M | -9.88% | 0.34% |
| JANE STREET GROUP, LLC | 02/14/2025 | 205,700 | $5.20 M | -15.56% | 0.31% |
| IKARIAN CAPITAL, LLC | 02/14/2025 | 205,500 | $5.19 M | -32.73% | 0.31% |
| TFG ASSET MANAGEMENT GP LTD | 02/21/2025 | 192,000 | $4.85 M | 100.00% | 0.29% |
| AXA S.A. | 02/14/2025 | 185,040 | $4.68 M | -0.16% | 0.28% |
| BANK OF NEW YORK MELLON CORP | 02/04/2025 | 181,610 | $4.59 M | 0.23% | 0.27% |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 02/14/2025 | 154,512 | $3.90 M | 100.00% | 0.23% |
| RAFFERTY ASSET MANAGEMENT, LLC | 02/14/2025 | 152,454 | $3.85 M | 67.55% | 0.23% |
| TD ASSET MANAGEMENT INC | 02/11/2025 | 143,878 | $3.64 M | -12.31% | 0.22% |
| BARCLAYS PLC | 02/13/2025 | 142,914 | $3.61 M | 9.61% | 0.22% |
| READYSTATE ASSET MANAGEMENT LP | 02/14/2025 | 142,038 | $3.59 M | -20.88% | 0.21% |
| POLAR ASSET MANAGEMENT PARTNERS INC. | 02/25/2025 | 137,550 | $3.48 M | 1,318.04% | 0.21% |
| RENAISSANCE TECHNOLOGIES LLC | 02/13/2025 | 136,588 | $3.45 M | 100.00% | 0.21% |
| DEUTSCHE BANK AG\ | 02/14/2025 | 121,501 | $3.07 M | 207.92% | 0.18% |
| MIRADOR CAPITAL PARTNERS LP | 01/15/2025 | 119,492 | $3.02 M | 2.88% | 0.18% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Celldex Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 221 institutional investors and hedge funds held shares of Celldex Therapeutics, Inc.. The most heavily invested institutionals were:
WELLINGTON MANAGEMENT GROUP LLP: 8.98 M
BlackRock Funding, Inc. /DE: 5.48 M
Kynam Capital Management, LP: 5.06 M
FMR LLC: 4.86 M
VANGUARD GROUP INC: 3.88 M
EVENTIDE ASSET MANAGEMENT, LLC: 3.75 M
111.15% of Celldex Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 80.79 M shares in the last 24 months. This purchase volume represents approximately $2.15 B in transactions.